> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Revokes EUAs on 3 Covid Tests
- URL: https://www.fdaweb.com/fda-revokes-euas-on-3-covid-tests/
- Published: 2023-05-10T12:00:00.000Z
- Updated: 2026-09-14T18:30:59.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5154411

*Federal Register* notice: FDA is announcing the revocation of three emergency use authorizations (EUAs) for Covid-19 tests because they are no longer being manufactured or distributed in the U.S. The affected tests are:

- Thermo Fisher Scientific’s OmniPATH Covid–19 Total Antibody ELISA Test
- Detect’s Covid–19 Test
- Cepheid’s Xpert Xpress SARS–CoV–2/Flu/RSV Test

FDA revoked the EUAs as requested by each authorization holder. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2023-05-10/pdf/2023-09879.pdf?ref=fdaweb.com).